Related Experiment Videos
Elevated plasma superoxide dismutase activity in patients with systemic sclerosis
A Morita1, H Minami, N Sakakibara
1Department of Dermatology, Nagoya City University, Medical School Nagoya, Japan.
Journal of Dermatological Science
|March 1, 1996
Summary
Systemic sclerosis patients show significantly higher plasma superoxide dismutase (SOD) activity, indicating increased antioxidant defenses. Elevated SOD levels may help assess disease progression and the presence of Raynaud
Area of Science:
- Biochemistry
- Immunology
- Vascular Biology
Background:
- Microvascular damage from free radicals is implicated in systemic sclerosis pathogenesis.
- Reactive oxygen species can trigger antioxidant defense mechanisms.
Purpose of the Study:
- To investigate plasma superoxide dismutase (SOD) activity in patients with systemic sclerosis.
- To determine if SOD activity correlates with disease progression or Raynaud's phenomenon.
Main Methods:
- Plasma samples were collected from 16 patients with systemic sclerosis and 89 healthy volunteers.
- Superoxide dismutase (SOD) activity was measured in plasma samples.
Main Results:
- Plasma SOD activity was significantly higher in systemic sclerosis patients (5.00 +/- 3.10 U/ml) compared to healthy volunteers (1.56 +/- 0.234 U/ml) (P < 0.001).
- Patients exhibiting Raynaud's phenomenon and/or skin sclerosis demonstrated particularly elevated SOD activity.
Conclusions:
- Elevated plasma SOD activity suggests an enhanced antioxidant response in systemic sclerosis.
- Plasma SOD activity may be a valuable biomarker for assessing sclerotic progression and Raynaud's phenomenon in systemic sclerosis patients.